Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab’s HASTE hypersonic suborbital test flights are positioning the company as a DoD vendor, with HASTE generating an estimated $9.5M–$22M per flight vs. $8M–$10M for standard Electron launches. The article cites ~$500M in secured HASTE contracts, including a $266M Space Force deal (12 flights) and a $190M Navy deal (20 flights), with backlog equivalent to more than half of projected 2026 revenue of $953M. Analysts expect revenue to nearly triple from 2025 to 2028, though the stock is described as still speculative at ~42x this year’s sales.

Analysis

The important change is not the launch itself, but that RKLB is turning a niche government testing need into a repeatable, high-utilization service line. That matters because defense test missions are far less price-elastic than commercial launch, so the mix shift can expand gross margin even if the absolute revenue contribution remains modest. In other words, this is more a margin-quality story than a headline growth story, and the market tends to underprice that distinction until it shows up in segment profitability.

Second-order, the real beneficiaries are not obvious launch rivals; they are the broader hypersonics supply chain and defense integrators that need frequent test cycles. LDOS can benefit as an ecosystem name if it keeps getting embedded in programs, but the bigger implication is that RKLB is building a switching-cost moat with procurement/process lock-in rather than with scale. The main competitive threat is internal execution: cadence, range availability, and capital intensity, not SpaceX in this particular niche.

The contrarian risk is that investors may be capitalizing contract value too aggressively while ignoring how slowly government programs monetize. Backlog only matters if flight cadence stays high and Neutron doesn’t absorb too much capital or management bandwidth. Falsifiers over the next 2-3 quarters: HASTE flight cadence disappoints, segment gross margin fails to improve, or 2026/2027 guidance gets pulled back; any of those would make the stock’s multiple hard to defend.

Key Decisions for Investors

• Buy RKLB on a 5-8% pullback over the next 1-3 weeks; this is a 6-12 month margin-mix thesis, not a chase-the-headline trade. Risk/reward is best if the stock consolidates before the next earnings print.
• Use 6-12 month call spreads on RKLB if implied volatility remains elevated after the pop; that keeps upside exposure to a defense-margin re-rate while limiting downside from valuation compression.
• Do not initiate a new position in LDOS or IRDM solely on this headline; set an alert only if either name wins incremental hypersonics/test-work or material satellite-services backlog, which would be a 1-2 year follow-through, not an immediate catalyst.
• If RKLB rallies more than 15% before the next quarterly update, take partial profits or overlay covered calls; the market may be ahead of actual cadence and EBITDA conversion.